Objective: To screen and analyze differentially expressed genes in pancreatic carcinoma tissues taken from Mongolian and Han patients by Affymetrix Genechip.
3 there are a large number of differentially expressed genes in pancreatic cancer tissue samples comparing Mongolian and Han population. These genes are closely related to the cell proliferation, differentiation, invasion, metastasis and multi-drug resistance in pancreatic cancer. They are also involved in the regulation of multiple important signaling pathways in organisms.
Background
Pancreatic cancer has the highest mortality among all the digestive system malignancies.
Its onset is occult, followed by rapid progress, so most patients are diagnosed late and lost the best treatment opportunities. Therefore, the search for specific and sensitive early diagnostic tools for the pancreatic cancer is particularly important to improve the prognosis of patients with pancreatic cancer and prolong their survival time [1] . Recent years, the completion of Human Genome Project and the maturation in gene microarray technology provide a large amount of information for high-throughput analysis of the occurrence and development of tumors, making genetic diagnosis an ideal early diagnostic method for most tumors. By analyzing genes involved in the generation and maintaining of malignant biological characteristics of pancreatic cancer, this method [2] can elucidate the molecular mechanism of pancreatic cancer. In this study, Affymetrix Gene Expression Profiling microarray was used to screen differentially expressed genes in pancreatic cancer samples of Mongolian and Han patients for further gene function analysis, in order to provide important reference data and experimental evidence for the elucidation of the molecular mechanism of pancreatic cancer development.
Methods

Reagents and Instruments
The required reagents Agilent RNA 6000 Nano Kit, GeneChip 3'IVT Express Kit, GeneChip 4 Hybridization Wash and Stain Kit, Trizol Kit, and QIAGEN RNeasy Total RNA Isolation kit were provided by Gekkai Gene Technology Co., Ltd. The main instruments used in the study included the Thremo Nanodrop 2000, Agilent 2100, GeneChip Hybridization Oven 645, GeneChip Fluidics Station 450, and GeneChip Scanner 3000.
Sample information
A total of 96 fresh tumor tissue specimens from patients with pancreatic malignancies surgically resected in the Second Affiliated Hospital of Nanchang University from March 2015 to May 2018 were collected. 66 of them were initially selected according to the following inclusion and exclusion criteria and these specimens were used for follow-up gene expression microarray assays.
Inclusion criteria: (1) Pathologically confirmed pancreatic ductal cell carcinoma;
(2) New cases diagnosed by our hospital for the first time; (3) Patients aged ≥ 18 years;
(4) Patients and their families agree to provide tissue specimens for scientific research and allow the publication of research data.
Exclusion criteria:
(1) Pathologically confirmed local vascular invasion and regional lymph node metastasis; (2) distant metastasis found by relevant examinations or during operation in our hospital; (3) with other malignant tumors or diabetes, hypertension, systemic diseases such as cardiovascular or cerebrovascular diseases; (4) patients who have received radiotherapy, chemotherapy, or other anti-neoplastic drugs before surgery;
(5) with a history of surgery in the past three years.
General information of patients:
Of the 66 patients, 32 were Mongolian and 34 were Han; 34 were males and 32 were females; the average age was 60.12; the youngest patient was 42 years-old and the oldest was 73 years-old; 24 cases were welldifferentiated, 38 cases were moderately differentiated, and 4 cases were poorly 5 differentiated.
Sample Total RNA Extraction and Quality Assurance
The collected samples were extracted and purified by Trizol kit and QIAGEN RNeasy Total RNA Isolation kit to obtain the total RNA. The samples were tested using Nanodrop 2000 and Agilent 2100 instruments and evaluated according to RNA concentration, A260/A280 value, RIN value and 28S/18S value. When the A260/A280 was between 1.7 and 2.2, RIN value was smaller than A26 and 28S/18S value were bigger than 0.7, the samples were qualified. The above procedures were strictly carried out in line with the reagent and instrument instructions.
Gene Microarray Hybridization
The double-stranded cDNA template was synthesized after mixing the purified total RNA with the internal reference poly-A RNA according to the instructions of the GeneChip 3′ IVT Express Kit. Then, the biotin-labeled amplified RNA (aRNA) was obtained by reverse transcription in vitro. The obtained aRNA was purified using the purification reagent in the kit and fragmented to prepare a hybridization reaction solution. The hybridization reaction solution was heated at the 98 °C waterbath for 10 min until the temperature of solution rose up to 45° C. Then the waterbath was retained at 45° C for more than 3 mins.
Meanwhile, 130 μL of the pre-hybridization solution in the kit was injected into the chip and kept in the hybridization oven at 45°C for 10 min. After that, the pre-hybridization solution was discarded, and 130 μL of the hybridization reaction solution was injected into the chip at 45°C and the hybridization was performed at 60 rpm for 16 h to complete the hybridization. Afterwards, automatic washing and dyeing was performed using the GeneChip Fluidics Station 450 instrument, then the chip was scanned to obtain data. 6
Real-time quantitative PCR verification
The top 10 differentially expressed genes in Han and Mongolian pancreatic cancer patients were selected and verified. Primers were synthesized according to the PCR primer information provided by the Primer Bank database (Table 1) . GAPDH was used as an internal reference and a two-step method was used. The expression of GAPDH was detected by qPCR. Using the expression level of GAPDH as the standard value "1", the 
Data Processing and Statistical Analysis
The data obtained by scanning was analyzed using the R-Project software in line with the following protocol:
(1) Filtering the background noise with the 20% lowest signal strength among all microarray probes;
(2) Using the software to plot the signal intensity distribution of the probes and the quadrantal diagram of the relative logarithm of the probe signal intensity, in order to evaluate the reliability and repeatability of the results of the differential expression profile microarray;
(3) Gene differential expression analysis was performed using the GCBI online analysis tool (https://www.gcbi.com.cn/gclib/html/index). GCBI (Gene-Cloud of Biotechnology Information) is a R-based online analysis software developed in China, which can conveniently process microarray data.
Through GCBI software, the microarray data was first processed by logarithmic standard to facilitate analysis, and differential genes were screened by statistical methods. Using the linear model based on empirical Bayesian distribution to calculate the P value of the significant difference in gene expression between the two groups, the screening criteria for gene expression with significant differences were defined as fold change>3.0 and P-value<0.05 ;
(4) Using software, scatter plots were drawn based on the signal intensity of the two sets of sample chips. The volcano plots are drawn based on the fold change and the P value of the difference test between the two groups of samples.
(5) Hierarchical cluster analysis was used to preliminarily classify the above microarray results from two dimensions -sample and gene differential expression patterns. 
Results
Sample total RNA quality inspection
Through total RNA quality testing, the total RNA of 55 out of 66 samples were qualified for follow-up study. 20 samples in Han patients and 20 in Mongolian patients were randomly selected. 12 male and 8 female Han patients and 11 male and 9 female Mongolian patients were selected. Among Han samples, 6 were well-differentiated, 10 were moderately differentiated and 4 were poorly differentiated; among Mongolian patients, 12 were welldifferentiated, and 8 were moderately differentiated.
Differentially Expressed Gene Test Results and Quality Assess ment
(1) After noise reduction, 36,866 out of 49395 probes included in the chip are selected for subsequent analysis.
(2) After analysis, a total of 970 genes were differentially expressed in the above 36866 probes, and the differential expression rate was 2.69%. Compared with the Han and Mongolian patients, the differentially expressed genes in the pancreatic cancer samples showed 257 genes were significantly up-regulated. A total of 713 genes were significantly down-regulated.
3 Data quality evaluation: The microarray signal intensity distribution curve is shown in The ordinate is the relative logarithmic signal strength and the abscissa is the sample name. As can be seen from the figure, the relative logarithm signal intensity distributions of each probe of the box plot are close to each other, confirming the repeatability of the data.
Analysis of Significant Differences in Sample Gene Expression
(1) The scatter plot is shown in (2) Figure 2 is a volcano plot drawn by the software based on the gene expression differential multiples and the P value of the significance test. The ordinate is the P value, and the abscissa is the logarithmic transformed difference multiplier value (base = 2). The red points indicate differentially expressed genes that meet the above significant differential expression screening conditions. some genes have similar expression patterns. These genes may have similar functions or participate in the same biological process. Genes with the highest differential expression times were named as a gene cluster. For example, the RASA2 gene cluster includes BIRC2, RASA2, ADAM17, RECQL, LYAR, and SDHD genes, of which the differential expression of RASA2 is the highest (2.36 times).
Differentially expressed genes bioinformatics analysis
(1) GO analysis: Based on the results of the differentially-expressed gene screening, 793 differentially expressed genes were retrieved from the Gene Ontology database. Among the three major categories of GO analysis, the BP classification contains a total of 597 differentially expressed genes. In MF classification, a total of 613 genes were included.
The CC classification contained a total of 573 differentially expressed genes; Figure 4 shows the top 10 GO categories classified according to the level of differentially expressed genes enriched in the three major classifications. The results showed significant differences between the two groups of samples. Among the expressed genes, the genes involved in biological processes mainly encode proteins that control the body's immune system, immune response, cell signal transduction, cell response to stimuli, and multiple feedback regulation; the molecular function-related genes mainly code for proteins related to endopeptidase activity, binding capacity to the same protein, enzyme regulatory activity, cytoskeletal protein binding ability, specific binding ability to protein domains, and protein molecule function regulation; the genes associated with cellular components are mainly involved in the plasma membrane structure, vacuoles, endoplasmic reticulum, cell gap junction, extracellular matrix and other structural proteins.
(2) Pathway analysis: After searching KEGG and BioCarta databases, a total of 28 cellular signaling pathways were differentially expressed between the two groups of samples, involving 178 genes, as shown in Figure 5 ; Tables 2, 3 , and 4 are a detailed list of differentially expressed genes contained in the three strongest enriched pathways (Focal adhesion, Pathways in cancer and Regulation of actin cytoskeleton respectively).
Real-time PCR verification
Results of real-time quantitative PCR detection of differentially expressed genes listed in CLPS, the expression level of differential genes in Mongolian pancreatic cancer tissues was significantly higher than that in Han pancreatic cancer tissues.
Discussion
The occurrence and development of pancreatic cancer is affected by many factors. A large number of studies have shown that the incidence of pancreatic cancer in different regions, races and even ethnic groups is significantly different. For example, Wormann SM [3] pointed out in his report that ethnic differences are one of the high-risk factors for the onset of pancreatic cancer; Investigation by Ma J [4] showed that from 1970 to 2009, the trend of the change in the mortality rate of pancreatic cancer in white and black people in the United States is diametrically opposite, suggesting that the prognosis of pancreatic cancer may be diverse between people with different genetic background [5] . At present, there are few studies on pancreatic cancer related to Mongolian population at home and abroad. There is no strong evidence to confirm that there is a significant difference in the prevalence and prognosis of pancreatic cancer between Mongolian and Han or other ethnic minorities [6] .
In this study, Affymetrix gene expression microarray was used to detect and analyze differentially expressed genes and their biological information in surgically resected pancreatic cancer tissue from Mongolian and Han patients. From the molecular level we explored the potential difference in the development of pancreatic cancer in different ethnic groups. This provides a reliable reference for further elucidating the generation and maintenance of malignant biological characteristics of pancreatic cancer.
In this study, through screening differentially expressed gene in Mongolian and Han pancreatic cancer tissue samples, we found that there were 1034 genes with significant different expression level between the two groups of samples, accounting for 2.69% of the total number of detected genes. Compared to the Han patients, 257 genes were significantly up-regulated and 712 were down regulated in the Mongolian patients.
According to gene ontology analysis, a total of 815 genes in the differentially expressed genes identified above were fully documented in the database. These differentially expressed genes were closely associated with the proliferation and differentiation of pancreatic cancer cells, invasion, metastasis and multidrug resistance according to the annotation of the gene biological function in the database. The highest score for 13 differential expression and significant difference in genes associated with biological processes was the PLA2G1B (Phospholipase A2, group IB) gene, which was significantly down-regulated (18.51 times) in Mongolian pancreatic cancer tissue samples. The protein encoded by the PLA2G1B gene is phospholipase A2, which plays a key role in membrane channel activation, information transmission, hemodynamics, and pathophysiology during pancreatic inflammation and after tissue injury [7, 8] .
In addition, the study by Abbenhardt C et al. [9] showed that the single nucleotide polymorphism of PLA2G1B gene is closely related to the susceptibility of rectal cancer. However, there are few reports on the association between this gene and pancreatic cancer at home and abroad.
Carboxypeptidase-1 (CPB1) gene has the highest score for the differential expression and significance among all the genes related to molecular function. Compared with the Han nationality, this gene was 33.76 times down-regulated in Mongolian pancreatic cancer tissues. The CPB1 gene mainly encodes pancreatic carboxypeptidase, an important serum marker for pancreatic dysfunction [10, 11] . In recent years, there have been relatively few researches on the association between CPB1 gene and malignant tumors. Jin et al. [12] showed that CPB1 has a noticeable abnormal expression in some breast cancer patients. The study of Bouchard P et al. [13] also suggested that CPB1 may be related to the lymph node metastasis of breast cancer. The CPB1 gene may be related to the structural components in extracellular matrix of the pancreatic cancer cell. The degree of enrichment of differential genes in GO classifications can, to a certain extent, reflect the degree of differences between Mongolian and Han pancreatic cancers in the above biological classifications, but using these results alone to evaluate the differences in the biological characteristics between Mongolian and Han pancreatic cancers could be inaccurate. The distribution of the above classification in pancreatic cancer-related genes in all populations needs to be considered.
Pathway analysis is currently the most commonly used method for the analysis of gene expression microarray differential gene bioinformatics. It retrieves detailed information on biological signal transduction pathways in the two authoritative databases KEGG and BioCarta, using the pathway as a unit and using all genes included as background, to analyze and calculate the significance levels of differentially expressed genes enriched in each pathway, thereby identifying the metabolic and signal transduction pathways that were significantly affected, and clarifying the molecular regulatory mechanisms that underlie the biological function of genes. Through Pathway analysis, we detected a total of 28 signal pathways differentially expressed between Mongolian and Han pancreatic cancer tissue samples, involving a total of 178 genes, among which the FAK (Focal Adhesion Kinase) pathway was differentially expressed at the highest degree of gene enrichment.
There were 37 members with significant expression differences, of which 34 were upregulated and 3 were down-regulated. The COL11A1 gene obtained the highest score for differential expression and significant difference test. This gene was 5-time up-regulated in Mongolian pancreatic cancer tissues.
The FAK signaling pathway can integrate multiple extracellular signals to regulate the expression of downstream molecules, thereby controlling the proliferation and apoptosis of cells. This pathway is cascaded with multiple signal transduction pathways in the body and is the central link of intracellular and extracellular signal transduction. [14, 15] . A large number of studies have confirmed that the abnormal activation of FAK signaling pathway is closely related to the occurrence and development of various malignant tumors [16] [17] [18] .
In the study of pancreatic cancer, Gao Z et al. [19] reported that the 
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JX Tables Table 1 Gene Gene Ontology analysis shows the top 10 GO categories classified according to the level of differentially expressed genes enriched in the three major classifications.
29 Figure 5 Pathway analysis shows the total of 28 cellular signaling pathways were differentially expressed between the two groups of samples.
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Figure 6
Relative expression levels of the differentially expressed genes in pancreatic cancer tissues of Mongolian and Han nationalities.
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